How to screen NAFLD patients for diabetes?

被引：0
|
作者：
Gonzalez-Moreno, Emmanuel I. [1 ]
García-Compean, Diego [1 ]
Gonzalez-Gonzalez, Jose A. [1 ]
Maldonado-Garza, Hector J. [1 ]
机构：
[1] Univ Hosp, Univ Autonoma Nuevo Leon, Dept Internal Med, Div Gastroenterol, Madero & Gonzalitos S-N, Mexico City 64460, DF, Mexico
来源：
ANNALS OF HEPATOLOGY | 2016年 / 15卷 / 05期
关键词：
FATTY LIVER-DISEASE; MELLITUS;
D O I：
10.5604/16652681.1212623
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：801 / 802
页数：2
相关论文
共 50 条
  • [31] Why We Should Screen for Type 2 Diabetes in High-Risk Patients
    Kirkman, M. Sue
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2013, 44 (04) : S371 - S374
  • [32] Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes
    Cusi, Kenneth
    Sanyal, Arun J.
    Zhang, Shuyu
    Hartman, Mark L.
    Bue-Valleskey, Juliana M.
    Hoogwerf, Byron J.
    Haupt, Axel
    DIABETES OBESITY & METABOLISM, 2017, 19 (11) : 1630 - 1634
  • [33] Prediction of NAFLD occurrence in prediabetes patients
    Vesa, Cosmin Mihai
    Behl, Tapan
    Nemeth, Sebestian
    Bratu, Ovidiu G.
    Diaconu, Camelia C.
    Moleriu, Radu Dumitru
    Negrut, Nicoleta
    Zaha, Dana C.
    Bustea, Cristiana
    Radu, Florentina Ionita
    Bungau, Simona
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 20 (06)
  • [34] Disturbed eating behaviors in adolescents with type 1 diabetes. How to screen for yellow flags in clinical practice?
    Eilander, Minke M. A.
    de Wit, Maartje
    Rotteveel, Joost
    Aanstoot, Henk Jan
    Bakker-van Waarde, Willie M.
    Houdijk, Euphemia C. A. M.
    Nuboer, Roos
    Winterdijk, Per
    Snoek, Frank J.
    PEDIATRIC DIABETES, 2017, 18 (05) : 376 - 383
  • [35] Hepatic IRS1 and β-catenin expression is associated with histological progression and overt diabetes emergence in NAFLD patients
    Enooku, Kenichiro
    Kondo, Mayuko
    Fujiwara, Naoto
    Sasako, Takayoshi
    Shibahara, Junji
    Kado, Akira
    Okushin, Kazuya
    Fujinaga, Hidetaka
    Tsutsumi, Takeya
    Nakagomi, Ryo
    Minami, Tatsuya
    Sato, Masaya
    Nakagawa, Hayato
    Kondo, Yuji
    Asaoka, Yoshinari
    Tateishi, Ryosuke
    Ueki, Kohjiro
    Ikeda, Hitoshi
    Yoshida, Haruhiko
    Moriya, Kyoji
    Yotsuyanagi, Hiroshi
    Kadowaki, Takashi
    Fukayama, Masashi
    Koike, Kazuhiko
    JOURNAL OF GASTROENTEROLOGY, 2018, 53 (12) : 1261 - 1275
  • [36] The Role of Medications for the Management of Patients with NAFLD
    Mazzella, Natalia
    Ricciardi, Laura M.
    Mazzotti, Arianna
    Marchesini, Giulio
    CLINICS IN LIVER DISEASE, 2014, 18 (01) : 73 - +
  • [37] Sonography in surveillance for HCC in NAFLD patients
    Radu, Pompilia
    Dufour, Jean Francois
    HEPATOMA RESEARCH, 2022, 8
  • [38] Management of NAFLD patients with advanced fibrosis
    Maya-Miles, Douglas
    Ampuero, Javier
    Gallego-Duran, Rocio
    Dingianna, Paola
    Romero-Gomez, Manuel
    LIVER INTERNATIONAL, 2021, 41 : 95 - 104
  • [39] The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular Risk
    Caussy, Cyrielle
    Aubin, Adrien
    Loomba, Rohit
    CURRENT DIABETES REPORTS, 2021, 21 (05)
  • [40] NAFLD and type 2 diabetes: A practical guide for the joint management
    Genua, Idoia
    Iruzubieta, Paula
    Rodriguez-Duque, Juan Carlos
    Perez, Antonio
    Crespo, Javier
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2023, 46 (10): : 815 - 825
12345